Drug Markets/Tranylcypromine Sulfate

Tranylcypromine Sulfate

2 NDCs across 2 manufacturers|2 Generic,0 Brand

Tranylcypromine Sulfate is used to treat depressive disorder and post-traumatic stress disorders, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Aug 16, 1985, and the first generic was approved Jun 29, 2006. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $3 million on Tranylcypromine Sulfate across 12,000 claims for 1,842 beneficiaries.

Tranylcypromine Sulfate is available as 2 NDCs from 2 manufacturers (2 generic, 0 brand), with NADAC prices from $0.58 to $0.58 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

2G / 0B

Manufacturers

2

competing in market

Price Spread

$0.58 – $0.58

per EA

7d Activity

20 flat

avg -3.7% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

2 manufacturers producing TRANYLCYPROMINE SULFATE

Drug Portfolio

2 NDCs total, 2 shown

Drug Price 7d Change
TRANYLCYPROMINE SULF 10 MG TAB
$0.5752
per EA
-3.68%
TRANYLCYPROMINE SULF 10 MG TAB
$0.5752
per EA
-3.68%

Frequently Asked Questions

What is Tranylcypromine Sulfate used to treat?

Tranylcypromine Sulfate is used to treat depressive disorder and post-traumatic stress disorders, per the National Library of Medicine's MED-RT classification.

When did Tranylcypromine Sulfate become available as a generic?

FDA approved the first generic Tranylcypromine Sulfate (ANDA) on Jun 29, 2006. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Tranylcypromine Sulfate?

In 2024, Medicare Part D spent $3 million on Tranylcypromine Sulfate across 12,000 claims for 1,842 beneficiaries.

How many Tranylcypromine Sulfate products are on the market?

The Tranylcypromine Sulfate drug market contains 2 NDCs from 2 manufacturers — 2 generic and 0 brand products.

What is the price range for Tranylcypromine Sulfate?

NADAC reference prices for Tranylcypromine Sulfate range from $0.5752 to $0.5752 per EA.

Which manufacturers make Tranylcypromine Sulfate?

2 manufacturers list Tranylcypromine Sulfate in NADAC. Ranked by number of NDCs, the largest are Actavis Pharma, Inc. (1), Strides Pharma Inc. (1).

How has the price of Tranylcypromine Sulfate changed recently?

Over the past 7 days, 0 Tranylcypromine Sulfate NDCs rose and 2 fell, with a market-wide average change of -3.7%.